SS
ONCY

Simplicity Solutions’s Oncolytics Biotech ONCY Stock Holding History

Simplicity Solutions’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,588
Closed -$13.9K – 1170
2023
Q1 		$13.9K Buy
+11,588
New +$18.2K ﹤0.01% 1152

Other funds holding ONCY

IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return

Simplicity Solutions's ONCY Position: Q2 2023 in Review

Simplicity Solutions sold out of Oncolytics Biotech (ONCY) in Q2 2023, closing a stake of 11,588 shares — an estimated $13.9K sold.

Simplicity Solutions first reported a position in ONCY in Q1 2023 and held it in 1 quarter. The position peaked at $13.9K in Q1 2023. 32 funds tracked by Wall St. Rank hold ONCY as of Q2 2023.

  • Simplicity Solutions reported no remaining Oncolytics Biotech position as of Q2 2023 after selling out during the quarter.
  • Simplicity Solutions sold 11,588 Oncolytics Biotech shares in Q2 2023, an estimated $13.9K.
  • Simplicity Solutions first reported a position in Oncolytics Biotech in Q1 2023 and held it in 1 quarter.
  • Simplicity Solutions's Oncolytics Biotech position peaked at $13.9K in Q1 2023.
  • 32 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2023.

Based on Simplicity Solutions's 13F filing for Q2 2023, filed 26 Jul 2023.